Cargando…
PCDHGB7 Increases Chemosensitivity to Carboplatin by Inhibiting HSPA9 via Inducing Apoptosis in Breast Cancer
Breast cancer is one of the most serious cancers worldwide, and chemotherapy resistance frequently drives cancer progression. Triple-negative breast cancer (TNBC) has a high recurrence rate and poor prognosis given its resistance to chemotherapy. In our previous study, we found a remarkable abnormal...
Autores principales: | Hou, Siqi, Shan, Ming, Gao, Chunyang, Feng, Xinxin, Yang, Yongheng, Zhang, Ruo, He, Yan, Zhang, Guoqiang, Zhang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652090/ https://www.ncbi.nlm.nih.gov/pubmed/31379979 http://dx.doi.org/10.1155/2019/6131548 |
Ejemplares similares
-
Upregulation of HSPA1A/HSPA1B/HSPA7 and Downregulation of HSPA9 Were Related to Poor Survival in Colon Cancer
por: Guan, Yufeng, et al.
Publicado: (2021) -
Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening
por: Dong, Shihua, et al.
Publicado: (2021) -
Hypermethylated PCDHGB7 as a Biomarker for Early Detection of Endometrial Cancer in Endometrial Brush Samples and Cervical Scrapings
por: Yuan, Jiangjing, et al.
Publicado: (2022) -
Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells
por: Liu, Tuoen, et al.
Publicado: (2017) -
Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson’s disease
por: Texier, Baptiste, et al.
Publicado: (2022)